Cepham Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
- Paid Up Capital ₹ 4.57 M
- Company Age 47 Year, 6 Months
- Last Filing with ROC 31 Mar 2016
- Satisfied Charges ₹ 20.01 Cr
- Revenue Growth %
- Ebitda
- Net Worth -10.42%
- Total Assets %
About Cepham Laboratories
Cepham Laboratories Limited (CLL) is a Public Limited Indian Non-Government Company incorporated in India on 03 August 1977 and has a history of 47 years and six months. Its registered office is in New Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.57 M.
The company has closed loans amounting to ₹20.01 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Bhupinder Singh, Jagdish, and Dewan Pruthi serve as directors at the Company.
Company Details
- Location
New Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230DL1977PLC008694
- Company No.
008694
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
03 Aug 1977
- Date of AGM
28 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Cepham Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhupinder Singh  | Additional Director | 19-Jun-2017 | Current |
| Jagdish | Director | 08-Jul-2016 | Current |
| Dewan Pruthi | Director | 10-Jun-1986 | Current |
Financial Performance of Cepham Laboratories.
Cepham Laboratories Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Cepham Laboratories?
In 2016, Cepham Laboratories had a promoter holding of 15.09% and a public holding of 84.91%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cebon India LimitedBhupinder Singh and Jagdish are mutual person
Cepham Milk Specialities LimitedDewan Pruthi is a mutual person
- Cepham Diary Development Ltd
Dewan Pruthi is a mutual person
Charges (Loans)
₹0
₹20.01 Cr
Charges Breakdown by Lending Institutions
- Central Bank Of India : 16.80 Cr
- State Bank Of Hyderabad : 3.21 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Dec 1993 | State Bank Of Hyderabad | ₹3.21 Cr | Satisfied |
| 20 Feb 1987 | Central Bank Of India | ₹16.80 Cr | Satisfied |
How Many Employees Work at Cepham Laboratories?
Unlock and access historical data on people associated with Cepham Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cepham Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cepham Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
